Aims To identify:
. Clinical indications for performing coagulation screens. . Abnormalities found in coagulation screens. . Management and follow up of abnormal coagulation screens.
Method A retrospective case note review of patients aged 0-16 years who had a coagulation screen during a 6 month period from 1 st January until 30th June 2017. Results 219 samples were analysed. 45% (n=99) were male and 55% (n=120) female, aged 4 days to 16 years. The most common indication for performing a coagulation screen was presence of a non-blanching rash 32% (n=71). Bloody diarrhoea 7% (n=19), paracetamol overdose 7% (n=15) and child protection medicals 5% (n=12) were the next most common indications. 66.7% (n=146) of samples had at least one abnormality. 29% (n=64) of prothrombin times (PT), 25% (n=55) of activated partial thromboplastin time (APTT) and 35% (n=81) thrombin times (TT) were outwith the normal values for age. 62% (n=91) had mildly abnormal results. Abnormal results were commonest in the 1 to 5 year old group 32% (n=47). In those with mildly abnormal results repeat samples were arranged in 16% (n=15), whereas in coagulation screens with greater abnormalities repeat sampling was arranged in 55% (n=30). Repeat samples were carried out at a median of 7 days from the original sample (range 0-129 days).
One patient received i.v. vitamin K for prolonged PT and 3 patients were referred to haematology. Two of who had family members with a clotting disorder and one had a new diagnosis of haemophilia B. Conclusions . The commonest reason for performing a coagulation screen was a non-blanching rash. . The commonest abnormality is a prolonged TT, followed by PT then APTT. . There is wide variability in follow up and timing of follow up of abnormal coagulation screens. . Children with mildly abnormal screens are least likely to have repeat sampling.
Recommendation 1. To develop a guideline to unify the follow up of abnormal coagulation screens.
Introduction G6PD is an important enzyme in red blood cells and its deficiency renders erythrocytes susceptible to haemolysis under conditions of oxidative stress induced by oxidant drugs, ingestion of fava beans or its constituents, exposure to naphthalene, henna application, diabetic ketoacidosis and infection. It is an X-linked recessive condition, but homozygous females may also be affected. It is a common problem in some countries such the Arabian Peninsula, Turkey and the Middle-East; particularly in the Sultanate of Oman it affects 20% of male population. The main presentation is acute intravascular hemolytic anaemia and neonatal jaundice. Other nonspecific features are of chronic anaemia when there is low-grade hemolysis. Aim Raise awareness in the recognition of uncommon precipitants of hemolysis and explore further updated discussion on the efficient management of acute intravascular haemolysis due to G6PD deficiency and its sequel as well as prevention.
Case report An 8-year-old child presented with generalised tonic clonic convulsion lasting about 20 min. On examination, he was pale and cyanosed with mild dehydration. Cardiac examination revealed a functional murmur. Abdominal examination was normal. Oxygen saturation was (SpO 2 ) at admission (78%) which did not improve significantly with the administration of 10 L/min oxygen via non-rebreather mask. Urine colour was red-brown. Acute hemolytic anaemia was suspected with the association of acquired methemaglobinemia based on clinical presentation and failure of oxygen therapy to improve SpO 2 . Initial investigations showed Hb 4.2 g/dL, high LDH, reticulocytes 16%, Serum ferritin 3840 ug/L and blood gases showed PaO 2 92 mm Hg and methaemoglobin 17%. Urine was strongly positive for haemoglobinuria. Careful history revealed that the day before presentation, the child was exposed to naphthalene at home. Naphthalene, available as small balls of different colours, is very attractive to children to play with and even putting the mouth as sweet and this precipitated hemolysis in this case. Outcome The child received oxygen, forced alkaline diuresis and ascorbic acid therapy, and made full recovery after 5 days hospitalisation.
